Characterization of immunochemically nonreactive urinary albumin

Clinical Chemistry

Volumn 50, Issue 12, 2004, Pages 2286-2291

  Osicka, Tanya M ^a,b   Comper, Wayne D ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b AusAm Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE MARKER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MICROALBUMINURIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DETERMINATION; PROTEIN URINE LEVEL; RADIOIMMUNOASSAY; URINALYSIS;

ALBUMINS; ALBUMINURIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENSITOMETRY; DIABETES COMPLICATIONS; DIABETES MELLITUS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RADIOIMMUNOASSAY;

EID: 9244223620     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.039743     Document Type: Article

References (16)

1. Greive KA, Eppel GA, Reeve S, Smith I, Jerums G, Comper WD. Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats. Am J Kidney Dis 2001;38:144-52.
2. Comper WD, Osicka TM, Jerums G. High prevalence of immuno-unreactive intact albumin in the urine of diabetic patients. Am J Kidney Dis 2003;41:336-42.
3. Comper WD, Osicka TM, Clark M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004;65:1850-5.
4. Brinkman JW, Bakker SJL, Gansevoort RT, Hillege HL, Kema IP, Gans ROB, et al. Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with high-performance liquid chromatography. Kidney Int 2004;in press.
5. Jenkins MA. Clinical application of capillary electrophoresis to unconcentrated human urine proteins. Electrophoresis 1997;18:1842-6.
6. Aronoff SL, Schnider S, Smeltzer J, Mackay W, Tchou P, Rushforth N, et al. Urinary excretion and renal clearance of specific plasma proteins in diabetes of short and long duration. Diabetes 1981;30:656-63.
7. Fletcher AP, Neuberger A, Ratcliffe WA. Tamm-Horsfall urinary glycoprotein. The chemical composition. Biochem J 1970;120:417-24.
8. Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 2003;42:658-76.
9. Chakraborty J, Below AA, Solaiman D. Tamm-Horsfall protein in patients with kidney damage and diabetes. Urol Res 2004;32:79-83.
10. Stevenson FK, Cleave AJ, Kent PW. The effect of ions on the viscometric and ultracentrifugal behaviour of Tamm-Horsfall glycoprotein. Biochim Biophys Acta 1971;236:59-66.
11. Yagame M, Suzuki D, Jinde K, Yano N, Naka R, Abe Y, et al. Urinary albumin fragments as a new clinical parameter for the early detection of diabetic nephropathy. Intern Med 1995;34:463-8.
12. Burne MJ, Panagiotopoulos S, Jerums G, Comper WD. Alterations in the renal degradation of albumin in early experimental diabetes: a new factor in the mechanism of albuminuria. Clin Sci 1998;95:67-72.
13. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD. Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 2000;49:1579-84.
14. Eppel GA, Nagy S, Jenkins MA, Tudball RN, Daskalakis M, Balazs NDH, et al. Variability of standard clinical protein assays in the analysis of a model urine solution of fragmented albumin. Clin Biochem 2000;33:487-94.
15. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.
16. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 2003;254:45-66.